Retina Implant AG, a German developer of subretinal implants to help restore sight of people with retinitis pigmentosa, has announced publication of results of a new clinical trial of its Alpha IMS system. Nine blind people received the 3×3 mm wireless microchip implants that feature a 1500 pixel resolution. The implants capture light and in (Read more...)
Category: News
Molteno3 Glaucoma Shunt Reduces IOP
In non-neovascular glaucoma, intraocular pressure (IOP) is reduced to a similar extent with the new 175-mm2 Molteno3 implant and the older 274-mm2 double-plate Molteno implant. Reuters Health Information
International nonproprietary name “auriclosene” approved by WHO for NovaBay’s NVC-422
NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biotechnology company focused on addressing the large unmet therapeutic needs of the global anti-infective market with first-in-class compounds such as its proprietary Aganocides®, today announced that the World Health Organization (WHO) has approved the international nonproprietary name (INN) “auriclosene” (pronounced awr-rih-CLO-zeen) for the Company’s lead Aganocide® compound NVC-422.
Tips to help reduce dry eyes
Some of the last days of winter can be among the worst for your eyes. Winter may be slowly giving way to spring, but the remaining cold days of the season can cause plenty of trouble for the eyes—trouble that is largely avoidable, says a Vanderbilt Eye Institute ophthalmologist.
Vision Services Need Urgent Review In Kenya To Address Age-Related Macular Degeneration
Despite current beliefs, the degenerative eye condition age-related macular degeneration is a common cause of vision impairment and blindness in sub-Saharan Africa, requiring an urgent review of vision services, according to a study by international r…
Sucampo launches RESCULA Eye Drops in the U.S.
Sucampo Pharmaceuticals, Inc. announced that RESCULA Eye Drops had been launched in the U.S. market.
Reading Impairments In Schizophrenia Revealed By Eye Movements
A study of eye movements in schizophrenia patients provides new evidence of impaired reading fluency in individuals with the mental illness. The findings, by researchers at McGill University in Montreal, could open avenues to earlier detection and int…
Hollenhorst Plaques in Diabetic Retinopathy Screening
Are cholesterol emboli being misdiagnosed as Hollenhorst plaques? The British Journal of Diabetes and Vascular Disease
AMD risk alleles fail to predict treatment response
The major risk alleles that influence the development of age-related macular degeneration do not predict response to therapy for the condition, a substudy of the CATT trial indicates.
News From The Annals Of Internal Medicine: Feb. 19, 2013
1. Acupuncture May be an Effective Alternative for Treating Seasonal Allergies Patients receiving acupuncture treatments for seasonal allergic rhinitis reported statistically significant improvements in symptoms and decreased use of medication compare…
Topical Treatment Of Dry Eye Disease
Eleven Biotherapeutics, a biopharmaceutical company creating novel and differentiated protein-based biotherapeutics, has published preclinical data in Proceedings of the National Academy of Sciences (PNAS) showing beneficial effects of EBI-005, the fi…
Electronic Eye Implant Gives Hope To The Blind
Promising results have shown that blind patients have regained their sight with a sub-retinal microchip, according to the first part of the second clinical trial for the device taking place in Germany. The patients involved in the study, published in…
AMD Risk Genes Do Not Predict Response to Therapy
Although certain genetic risk alleles are strong predictors for the development of neovascular AMD, they do not affect the response to anti-VEGF drug therapy, researchers report. Medscape Medical News
Sucampo’s RESCULA 0.15% now available by prescription across the U.S.
Sucampo Pharmaceuticals, Inc. today announced that RESCULA (unoprostone isopropyl ophthalmic solution) 0.15% is now available by prescription across the United States. The U.S. Food and Drug Administration (FDA) approved a sNDA for RESCULA for the lowe…
Posterior Corneal Astigmatism: Not to Be Ignored!
Dr. William Culbertson explains why ignoring posterior corneal astigmatism may yield incorrect estimation of total corneal astigmatism and less-than-satisfactory surgical results. Medscape Ophthalmology
Potential Link Revealed Between Parkinson’s And Visual Problems
The most common genetic cause of Parkinson’s is not only responsible for the condition’s distinctive movement problems but may also affect vision, according to new research by scientists at the University of York. Parkinson’s, the second most common fo…
CMV Retinitis Drug Recalled
(MedPage Today) — One lot of cidofovir for intravenous infusion (Vistide), used to treat cytomegalovirus (CMV) retinitis in AIDS patients, has been recalled because of particulate matter in some vials, the FDA said.
Open-Angle Glaucoma: Still Unclear Which Treatment Is Best
Current available research does not identify the most effective glaucoma treatment, Medscape Medical News
Darkness Therapy Helps To Restore Vision
Restoring vision might sometimes be as simple as turning out the lights. That’s according to a study reported in Current Biology, a Cell Press publication, in which researchers examined kittens with a visual impairment known as amblyopia before and aft…
Clinical Notes: Internet Flu Tracker Flops
(MedPage Today) — Google’s Flu Trends surveillance system did not do so well in tracking this season’s influenza numbers. Also this week: a multiple sclerosis drug will be tested in amyotrophic lateral sclerosis.